Atobarrier365 Cream Hit 10 Million Units — Here's Why It Keeps Winning

Estra (Amorepacific's derma line) just picked up the 2026 Brand of the Year award from the Korean Advertising Society — and the citation specifically calls out its TV campaign for expanding its customer base and sharpening brand recognition. The ceremony was held October 30 at Paradise Hotel in Busan, and Estra was one of six brands selected this year.

The award that actually tells you something useful: the Korean Advertising Society has been running this award since 2006, given to brands that demonstrate measurable results in customer satisfaction and brand equity through marketing communication. It's not a popularity vote — it's an industry body assessment, which makes it a different kind of signal than a retailer ranking.

But the retailer ranking is also there. The Atobarrier365 Cream took first place in the cream category at the Olive Young Awards in both 2024 and 2025 — two consecutive years. That's the kind of repeat win that tells you it's not a one-cycle trend.

The cumulative sales number: as of January this year, the Atobarrier365 Cream crossed 10 million units sold. That's a single SKU, not a product line.

The brand's background matters here. Estra traces back to 1982, when it started as Taepyeong Pharmaceutical — building skin-barrier research at a time when the derma-cosmetic category barely existed in Korea. The sensitive-skin specialization isn't a recent pivot; it's been the core focus for decades.

Where it's heading: Estra is actively expanding into the US and European markets, positioning itself as a K-derma brand globally. The domestic track record — Olive Young dominance, a major advertising award — is clearly the foundation they're building that international push on.

If the Atobarrier365 Cream has been sitting in your cart, the back-to-back Olive Young cream category wins and the 10-million-unit milestone are about as strong a signal as you'll get that this one has staying power beyond the hype cycle.